Bloomberg Intelligence cover image

Novo Nordisk Gets US Approval for Wegovy Obesity Pill 

Bloomberg Intelligence

00:00

Low-cost carriers and premium strategy

Discussion of Spirit, Frontier and whether low-cost carriers will add premium offerings to boost revenue.

Play episode from 23:02
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app